You Are Here:
This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia.
Release Date: September 2014
- The USPSTF recommends the use of low-dose aspirin (81 mg/d) as preventive medication after 12 weeks of gestation in women who are at high risk for preeclampsia.
Grade: B recommendation.
|Supporting Document||Related Items|
|Recommendation Statement (PDF File, 165 KB; PDF Help)||Clinical Summary (PDF File, 47 KB; PDF Help)|
|Consumer Fact Sheet (PDF File, 198 KB; PDF Help)|
|Evidence Summary (PDF File, 355 KB; PDF Help)||Final Evidence Review (PDF File, 1.4 MB; PDF Help)|
Current as of September 2014
Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia, Topic Page. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspsaspg.htm